Adma Biologics, Inc.
ADMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001368514
No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.
13F holders, Q3 2025
Institutional positions in Adma Biologics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 366
- +2 vs. Q2 2025
- Shares held
- 219.3M
- +8.51M (+4.0%) vs. Q2 2025
- Total value
- $3.28B
- −$558.6M (−14.6%) vs. Q2 2025
- New holders
- 65
- 98 more added
- Sold out
- 63
- 160 more reduced
5 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 322 | $1.70B |
| Q1 2026 | 358 | $1.91B |
| Q4 2025 | 357 | $4.02B |
| Q3 2025 | 366 | $3.28B |
| Q2 2025 | 369 | $3.84B |
| Q1 2025 | 347 | $4.07B |
| Q4 2024 | 321 | $3.50B |
| Q3 2024 | 306 | $4.16B |
| Q2 2024 | 253 | $2.03B |
| Q1 2024 | 214 | $1.16B |
| Q4 2023 | 184 | $764.6M |
| Q3 2023 | 188 | $612.7M |
| Q2 2023 | 179 | $610.6M |
| Q1 2023 | 163 | $547.2M |
| Q4 2022 | 160 | $592.2M |
| Q3 2022 | 130 | $315.4M |
| Q2 2022 | 113 | $236.0M |
| Q1 2022 | 105 | $189.9M |
| Q4 2021 | 88 | $137.1M |
| Q3 2021 | 72 | $47.3M |
| Q2 2021 | 90 | $68.6M |
| Q1 2021 | 104 | $85.4M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Adma Biologics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −13,107−100.0% | Sold out |
| Dakota Wealth Management | 0 | $0 | 0.00% | −12,659−100.0% | Sold out |
| Gallacher Capital Management LLC | 0 | $0 | 0.00% | −12,153−100.0% | Sold out |
| Journey Strategic Wealth LLC | 0 | $0 | 0.00% | −12,080−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −12,050−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −12,085−100.0% | Sold out |
| Syon Capital LLC | 0 | $0 | 0.00% | −11,780−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,457−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −11,241−100.0% | Sold out |
| Concurrent Investment Advisors, LLC | 0 | $0 | 0.00% | −11,095−100.0% | Sold out |
| RSM US Wealth Management LLC | 0 | $0 | 0.00% | −11,076−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −11,065−100.0% | Sold out |
| City Center Advisors, LLC | 0 | $0 | 0.00% | −10,597−100.0% | Sold out |
| Sawgrass Asset Management LLC | 0 | $0 | 0.00% | −10,223−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −10,100−100.0% | Sold out |
| Evergreen Capital Management LLC | 0 | $0 | 0.00% | −10,097−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −10,063−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −9,031−100.0% | Sold out |
| Mount Yale Investment Advisors, LLC | 0 | $0 | 0.00% | −6,099−100.0% | Sold out |
| Glenmede Investment Management, LP | 0 | $0 | 0.00% | −3,737−100.0% | Sold out |
| Mark Sheptoff Financial Planning, LLC | 0 | $0 | 0.00% | −3,200−100.0% | Sold out |
| Nkcfo LLC | 0 | $0 | 0.00% | −2,413−100.0% | Sold out |
| Cullen/Frost Bankers, Inc. | 0 | $0 | 0.00% | −2,042−100.0% | Sold out |
| Park Square Financial Group, LLC | 0 | $0 | 0.00% | −1,056−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −842−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −588−100.0% | Sold out |
| Colonial Trust Co | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Annis Gardner Whiting Capital Advisors, LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| UMA Financial Services, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Avantax Advisory Services, Inc. | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| E Fund Management Co., Ltd. | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Parkworth Wealth Management, Inc. | – | – | – | – | Not filed |